Science & Technology Review
|
2024, 42(8): 76-82
• Exclusive:Key Technologies and Innovation Drive •
Research progress of ischemia-free organ transplantation
Full
LI Yefu, ZHANG Mingxi, WU Shaohai, CHEN Honghui, HUANG Jinbo, LU Changtao, YAO Yao, ZHAO Qiang, HE Xiaoshun
Affiliations
Published: 2024-04-28
doi: 10.3981/j.issn.1000-7857.2023.12.01824
Outline
Ischemia-reperfusion injury (IRI) is a congenital defect of organ transplantation. Extended criteria donor (ECD) organs are more susceptible to IRI, resulting in a serious contradiction between supply and demand. Although the breakthrough of machine perfusion technology has brought the hope of alleviating IRI, it still cannot eradicate the organ damage caused by IRI. Ischemia-free organ transplantation can completely avoid IRI, improve graft function, improve the prognosis of patients, and expand the source of graft. This article summarizes the latest progress of ischemia-free organ transplantation, and looks forward to the future development of ischemia-free organ transplantation, so as to help researchers and clinicians in related fields understand the latest research status of ischemia-free organ transplantation and provide reference.
ischemia-free organ transplantation(IFOT)
/
normothermic machine perfusion(NMP)
/
ischemia reperfusion injury
/
early allograft dysfunction
LI Yefu, ZHANG Mingxi, WU Shaohai, CHEN Honghui, HUANG Jinbo, LU Changtao, YAO Yao, ZHAO Qiang, HE Xiaoshun.
Research progress of ischemia-free organ transplantation[J].
Science & Technology Review,
2024
, 42
(8)
: 76
-82
.
DOI: 10.3981/j.issn.1000-7857.2023.12.01824
Year 2024 volume 42 Issue 8
PDF
615
182
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2023.12.01824
- Receive Date:2023-12-03
- Online Date:2024-05-22
- Published:2024-04-28